Effect of Cequa™ in Subjects With Dry Eye Disease

Completed · Phase 4

Conditions studied: Dry Eye Disease

In brief

This is a Phase 4, multicenter, single arm, 12 week study in subjects with dry eye disease, which is inadequately controlled by cyclosporine 0.05% ophthalmic emulsion.

Key facts

Study ID
NCT04357795
Run by
Sun Pharmaceutical Industries Limited
People needed
135
Starts
2020-06-29
Expected to finish
2022-06-24
Last updated by the study team
2024-02-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.